Advertisement
Supplier News
Subscribe to Supplier News

The Lead

Vascular Solutions Gets Clearance for Tumor Treating Gel-Block

November 25, 2014 9:44 am | News | Comments

Vascular Solutions gets clearance from the FDA for tumor treating gel blocks. Read more...                             

Amgen-Sponsored Gastric Cancer Studies Terminated

November 24, 2014 11:01 am | News | Comments

Amgen announced...

Shire Relocates 500 Jobs to Massachusetts

November 20, 2014 1:54 pm | News | Comments

Shire is transferring 500 jobs to ...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Cardiome Finds Distributor for AFib Drug in South Africa

November 19, 2014 9:59 am | News | Comments

Cardiome entered into a new partnership with Pharmacare Ltd to sell and distribute its AFib drug in South Africa. Read more...                     

Pfizer's Meningococcal Group B Vaccine Is Now Available

November 18, 2014 1:58 pm | News | Comments

Pfizer Inc. announced that Trumenba (Meningococcal Group B Vaccine) is now available for order by healthcare providers in the United States. Read more...

Study Lifts Cloud Over Heart Drugs

November 17, 2014 12:25 pm | by Marilynn Marchione - AP Chief Medical Writer | News | Comments

A major study lifts a cloud around blockbuster drugs for lowering cholesterol. Read more...                             

Advertisement

Online Tool Provides Health Info by ZIP Code, District

November 13, 2014 1:15 pm | News | Comments

For the first time, anyone can easily access comprehensive California health statistics by ZIP code, city and legislative district thanks to a new web tool created by the UCLA Center for Health Policy Research.  Read more...

Roche Teams Up with LabCentral to Support Biotech Startups

November 13, 2014 12:27 pm | News | Comments

LabCentral and Roche announced an agreement in which Roche would provide technology and financial support to LabCentral, a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. Read more...

AstraZeneca, Isis Pharmaceuticals to Co-Develop Targeted Delivery

November 13, 2014 9:57 am | News | Comments

Isis Pharmaceuticals Inc. and AstraZeneca announced a strategic alliance to discover and develop novel delivery methods for antisense oligonucleotides. The new delivery approaches seek to target the desired tissue more effectively. Read more...                   

RA Drugs May Promote Vascular Health

November 11, 2014 12:49 pm | News | Comments

HemoShear, a discovery stage biotechnology company, and Janssen will report data showing that a subset of compounds used to treat RA also suppress inflammation and have the potential to promote vascular health. Read more...

New Research Venture Aims to Lower Cost of Meds

November 11, 2014 10:22 am | News | Comments

Bath is the first institution outside the United States to receive funding from the US Food & Drugs Administration (FDA), for a major new research collaboration that will strive to open up the pharmaceutical drugs market and enable the design of better and cheaper medicines. Read more...

Advertisement

Google, CEO Donate to Ebola Fight

November 11, 2014 10:16 am | News | Comments

Google is launching a campaign to help fight Ebola by contributing $2 for every dollar people donate to a slew of nonprofits such as Save the Children and the Doctors Without Borders. Read more...

Dendreon Corporation Files for Bankruptcy

November 10, 2014 1:37 pm | by Tom Murphy - AP Business Writer | News | Comments

The company had high hopes for an innovative prostate cancer treatment but sales of the drug fell extremely short of expectations. Read more...                    

Lycera's Oral Immunotherapy May Have Anti-Cancer Activity

November 7, 2014 1:13 pm | News | Comments

Lycera Corp., a biopharmaceutical company developing breakthrough oral immune modulators to treat autoimmune disease and cancer, announced that data on the anti-tumor activity of the company’s novel synthetic RORgamma agonist product candidates were presented at the Society for Immunotherapy of Cancer (SITC) annual meeting being held in National Harbor, MD. Read more...

Mylan Launches Generic Loestrin 24 Fe

November 7, 2014 12:41 pm | News | Comments

Mylan Inc. announced the U.S. launch of its Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg and Ferrous Fumarate, which is the generic version of Warner Chilcott's Loestrin 24 Fe. Read more...

Creation of Montreal Pharma Company for $6.4M

November 6, 2014 9:49 am | News | Comments

The IRCM just signed an agreement with a leading international investment firm, Sanderling Ventures, to create Liphorus Pharmaceuticals. Up to $6.4 million will be invested in the new spinoff company in the coming years. Read more...

Advertisement

Generic Prilosec Gets Final ANDA Approval

November 6, 2014 9:44 am | News | Comments

Glenmark Generics Inc. USA, has been granted final approval for its abbreviated new drug application (ANDA) from the FDA for Omeprazole Delayed Release Capsules, their generic version of Prilosec by AstraZeneca. Read more...

FDA Approves Janssen's Hep C Drug

November 6, 2014 9:26 am | News | Comments

Janssen Therapeutics, Division of Janssen Products, LP (Janssen) announced the U.S. Food and Drug Administration (FDA) has approved Olysio(simeprevir), a hepatitis C virus (HCV) NS3/4A protease inhibitor, in combination with sofosbuvir as an all-oral, interferon- and ribavirin-free treatment option for genotype 1 chronic hepatitis C (CHC) infection in adult patients. Read more...

Roche to Invest $470M on Diagnostics

November 5, 2014 2:14 pm | News | Comments

Roche announced it will invest 450 million Swiss Francs ($470 million) over the next three years to establish a new diagnostic manufacturing facility at the Suzhou Industrial Park, in Suzhou, China. Read more...

BDSI's Opioid Dependence Treatment Now Available in U.S.

November 3, 2014 1:23 pm | News | Comments

BioDelivery Sciences International, Inc.announced that Bunavail (buprenorphine and naloxone) buccal film (CIII) is now commercially available. Read more...                                               

Game Changing Migraine Med to be Available November 2014

October 31, 2014 12:54 pm | News | Comments

Migranade Inc announced the new migraine medication will be available to the 36 million U.S. migraine sufferers November 2014. Read more...                    

Profectus BioSciences Gets $9.5M DoD Funding for Ebola/Marburg Vaccine

October 31, 2014 10:00 am | News | Comments

Profectus BioSciences Inc. announced that the DoD through the Medical Countermeasure Systems-Joint Vaccine Acquisition Program (MCS-JVAP), a subordinate command of the Joint Program Executive Office for Chemical and Biological Defense, Edgewood, MD, has contracted the manufacture and IND-enabling preclinical testing of the Profectus trivalent Ebola/Marburg vaccine.  Read more...

Specialized Therapeutics' Cancer Drug to be PBS Listed

October 31, 2014 9:33 am | News | Comments

Australian biopharmaceutical company Specialized Therapeutics Australia (STA) is announced Abraxane (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine, will be reimbursed via the Pharmaceutical Benefits Scheme (PBS) for patients with metastatic pancreatic cancer from November 1. Read more...

TNIB to Start 90-Day HIV/AIDS Trial in Nigeria

October 30, 2014 1:16 pm | News | Comments

TNI BioTech Inc., a specialty pharmaceutical company involved in the manufacture, distribution and marketing of novel, patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system, through its wholly owned subsidiary TNI BioTech International Ltd., announces the initiation of a 90-day bridging trial in Nigeria of Lodonal in patients with HIV/AIDS. Read more...

Google Developing Pill to Detect Cancer

October 29, 2014 12:46 pm | by Brandon Bailey - AP Technology Writer - Associated Press | News | Comments

Google is working on a cancer-detecting pill in its latest effort to push the boundaries of technology. Read more...                                          

Pfizer's Antidepressant May Not Affect Sexual Function

October 29, 2014 10:19 am | News | Comments

Pfizer Inc. announced the publication of a clinical study in the Journal of Clinical Psychiatry showing comparable sexual function in adult patients diagnosed with major depressive disorder (MDD) treated daily with Pristiq Extended Release Tablets 50mg and 100mg doses versus placebo. Read more...

Boehringer Ingelheim, Lilly Restructure Diabetes Alliance

October 29, 2014 10:01 am | News | Comments

In a move that will strengthen their alliance by enhancing efficiencies and enabling greater focus on product launches, Boehringer Ingelheim and Eli Lilly and Company are changing the operational and financial structure of their diabetes alliance in certain countries. Read more...

J&J Launches Asia Pacific Innovation Center

October 28, 2014 5:33 pm | News | Comments

Johnson & Johnson Innovation announced the opening of the Asia Pacific Innovation Center, located in Shanghai with satellites in Singapore, Australia and Japan. Read more...                                   

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading